Genetically transferred central and peripheral immune tolerance via retrovital-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes

Molecular Medicine

Volumn 3, Issue 3, 1997, Pages 212-224

  Zambidis, Elias T ^b   Kurup, Anupama ^c   Scott, David W ^a  

^a HOLLAND LABORATORY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; EXPRESSION VECTOR; GENE TARGETING; HEMATOPOIETIC STEM CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS;

EID: 0030996386     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401674     Document Type: Article

References (46)

1. Billingham RE, Brent L, Medawar PB. (1953) Actively acquired tolerance of foreign cells. Nature 172: 603-606.
2. Chiller JM, Habicht GS, Weigle WO. (1970) Cellular sites of immunologic unresponsiveness. Proc. Natl. Acad. Sci. U.S.A. 65: 551-556.
3. Borel Y, Lewis RM, Stollar BD. (1973) Prevention of murine lupus nephritis by carrier-dependent induction of immunologic tolerance to denatured DNA. Science 182: 76-78.
4. Ildstad ST, Sachs DH. (1984) Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307: 168-170.
5. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. (1984) Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548-551.
6. Roberts JL, Sharrow SO, Singer A. (1990) Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 171: 935-940.
7. Oehen SV, Ohashi PA, Buerki K, Hengartuer H, Zinkernagel RM, Aichele P. (1994) Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158: 342-352.
8. Nemazee D, Bürki K. (1989) Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sci. U.S.A. 86: 8039-8043.
9. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
10. Higgins PJ, Weiner H. (1988) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-445.
11. Critchfield JM, Racke MK, Zuniger-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ. (1994) T cell deletion in high dose antigen dose therapy of autoimmune encephalomyelitis. Science 263: 1139-1143.
12. Ryan JJ, Gness RE, Hathcock KS, Hodes RJ. (1984) Recognition and response to alloantigens in vivo. J. Immunol. 133: 2343-2350.
13. Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H. (1989) Tolerance induction of allo-class II antigen-reactive L3T4 and helper T cells and prolonged survival of the corresponding class II H-2 disparate skin graft. J. Immunol. 143: 1447-1452.
14. Madsen JC, Superina RA, Wood KJ, Morris PJ. (1988) Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332: 161-164.
15. Ramsdell F, Lantz T, Fowlkes BJ. (1989) A non-deletional mechanism of thymic self tolerance. Science 246: 1038-1041.
16. Roberts JL, Sharrow SO, Singer A. (1990) Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 332: 161-164.
17. Gao E-K, Lo D, Sprent J. (1990) Strong T-cell tolerance in parent/F1 bone marrow chimeras prepared with supralethal irradiation: Evidence for clonal deletion and anergy. J. Exp. Med. 171: 1101-1121.
18. Sachs DH, Bodine DH, Moulton DA, Pearson DS, Nienhuis AW, Sykes M. (1993) Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene. Transplant. Proc. 25: 348-349.
19. Sutkowski N, Kuo M-L, Varela-Echavarria A, Dougherty JP, Ron Y. (1994) A murine model for B-lymphocyte somatic cell gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91: 8875-8879.
20. Webb S, Morris C, Sprent J. (1990) Extra-thymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63: 1249-1256.
21. Eynon EE, Parker DC. (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138.
22. Fuchs EJ, Matzinger P. (1992) B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
23. Buhlmann JE, Foy TM, Aruffo A, Cerassi KM, Ledbetter JA, Green WR, Xu JC, Shultz LD, Roopesian D, Flavell RA, Fast L, Noelle RJ, Durie FH. (1995) In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2: 645-653.
24. Gilbert KM, Weigle WO. (1994) Tolerogenicity of resting and activated B cells. J. Exp. Med. 179: 249-258.
25. Soloway P, Fish S, Passmore H, Gefter M, Coffee R, Manser T. (1991) Regulation of the immune response to peptide antigens: Differential induction of immediate-type hypersensitivity and T-cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med. 174: 847-858.
26. Lai M-Z, Ross D, Guillet JG, Briner T, Gefter M, Smith JA. (1987) T lymphocyte response to bacteriophage λ repressor cl protein. J. Immunol. 139: 3973-3980.
27. Zaghouani H, Steinman R, Nonacs R, Shah H, Gerhard W, Bona C. (1993) Presentation of a viral T-cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259: 224-227.
28. Zambidis ET, Scott DW. (1996) Epitope-specific tolerance induction with an engineered immunoglobulin. Proc. Natl. Acad. Sci. U.S.A. 93: 5019-5024.
29. Allain JP, Frommel D. (1976) Patterns of immune response to Factor VIII in hemophilia A. Blood 47: 973-982.
30. Yang Y, Li Q, Ertl HC, Wilson JM. (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.
31. Tripathy SK, Black HB, Goldwasser E, Leiden JM. (1996) Immune response to trans-gene-encoded proteins limits the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2: 545-550.
32. Kang J, Wither J, Hozumi N. (1990) Proc. Natl. Acad. Sci. U.S.A. Long-term expression of a T-cell receptor β-chain in mice reconstituted with retrovirus-infected hematopoietic stem cells. 87: 9803-9087.
33. Keller G, Paige C, Gilboa E, Wagner EF. (1985) Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature 318: 149-154.
34. v mice. Cell 42: 71-79.
35. Bodine DM, Karlsson S, Nienhuis AW. (1989) Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 86: 8897-8901.
36. Grosschedl R, Weaver D, Baltimore D, Costantini F. (1984) Introduction of a μ-immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody. Cell 38: 647-658.
37. Weiss S, Bogen B. (1991) MHC class II-restricted presentation of intracellular antigen. Cell 64: 767-776.
38. Bikoff E, Birshtein BK. (1986) T cell clones specific for IgG2a of the a allotype: Direct evidence for presentation of endogenous antigen. J. Immunol. 137:28-34.
39. Yurin VL, Rudensky AY, Mazel SM, Blechman JM. (1989) Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule. Eur. J. Immunol. 19:1685-1691.
40. Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, Bosma MJ. (1984) Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J. Immunol. 132: 1804-1808.
41. Sprent J, Schaefer M, Hurd M, Suth CD, Ron Y. (1991) Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174: 717-728.
42. Ally BA, Hawley TS, McKall-Faienza KJ, Kundig TM, Oehen SU, Pircher H, Hawley RG, Ohashi PS. (1995) Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 155: 5404-5408.
43. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J. Exp. Med. 180: 631-640.
44. Zambidis E, Barth R, Scott DW. (1997) Both resting and activated B lymphocyte expressing engineered peptide-immunoglobulin molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J. Immunol. 158: 2174.
45. Crispe IN. (1994) Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1: 347-349.
46. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413.